| # | Drug | Count |
|---|---|---|
| 0 | ACETAMINOPHEN | 259 |
| 1 | DICLOFENAC SODIUM | 259 |
| 2 | RITUXIMAB | 257 |
| 3 | DICLOFENAC | 255 |
| 4 | ADALIMUMAB | 246 |
| 5 | SECUKINUMAB | 244 |
| 6 | METHOTREXATE SODIUM | 241 |
| 7 | NAPROXEN SODIUM | 241 |
| 8 | SULFASALAZINE | 228 |
| 9 | ADALIMUMAB-ADAZ | 227 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CAFFEINE CITRATE | 138 | 0.0610 |
| 1 | TRIPROLIDINE HYDROCHLORIDE | 6 | 0.0331 |
| 2 | XEROPHYLLUM ASPHODELOIDES, ACONITUM NAP., ANACARDIUM ORIENTALE, APIS MEL., BRYONIA, CANTHARIS, CROTON, GRAPHITES, GRINDELIA, MEZEREUM, NUX VOM., RANUNC. BULB., RHUS TOXICODENDRON, SARSAPARILLA, SULPHUR, ECHINACEA, RUMEX CRISP.,TARAXACUM, URTICA UR. | 1 | 0.0263 |
| 3 | HYDROCORTISONE BUTYRATE | 49 | 0.0257 |
| 4 | CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL | 7 | 0.0233 |
| 5 | ASIAN GINSENG | 9 | 0.0228 |
| 6 | TRICLOSAN | 11 | 0.0206 |
| 7 | CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE | 13 | 0.0203 |
| 8 | NEOMYCIN OINTMENT | 48 | 0.0202 |
| 9 | COCOA BUTTER, PHENYLEPHRINE HCL | 1 | 0.0200 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 305 |
| 1 | Corticosteroid [EPC] | 262 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 258 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 252 |
| 4 | Interleukin-17A Antagonist [EPC] | 244 |
| 5 | Aminosalicylate [EPC] | 243 |
| 6 | Interleukin-6 Receptor Antagonist [EPC] | 242 |
| 7 | Vitamin C [EPC] | 228 |
| 8 | Interleukin-23 Antagonist [EPC] | 218 |
| 9 | Angiotensin Converting Enzyme Inhibitor [EPC] | 216 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-12 Antagonist [EPC] | 215 | 0.0021 |
| 1 | Antirheumatic Agent [EPC] | 213 | 0.0020 |
| 2 | Histamine-1 Receptor Antagonist [EPC] | 159 | 0.0019 |
| 3 | Antiseptic [EPC] | 8 | 0.0019 |
| 4 | Aminosalicylate [EPC] | 243 | 0.0018 |
| 5 | Interleukin-6 Receptor Antagonist [EPC] | 242 | 0.0018 |
| 6 | Angiotensin Converting Enzyme Inhibitor [EPC] | 216 | 0.0016 |
| 7 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 31 | 0.0016 |
| 8 | Selective T Cell Costimulation Modulator [EPC] | 198 | 0.0014 |
| 9 | Phosphodiesterase 4 Inhibitor [EPC] | 207 | 0.0013 |